145 related articles for article (PubMed ID: 32769325)
1. Immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its correlation with clinicopathological parameters.
Lengare PV; Sinai Khandeparkar SG; Joshi AR; Gogate BP; Solanke SG; Gore SH
Indian J Pathol Microbiol; 2020; 63(3):376-381. PubMed ID: 32769325
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Vimentin in Invasive Breast Carcinoma and Its Correlation with Clinicopathological Parameters.
Khillare CD; Sinai Khandeparkar SG; Joshi AR; Kulkarni MM; Gogate BP; Battin S
Niger Med J; 2019; 60(1):17-21. PubMed ID: 31413430
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 overexpression associates with favourable prognostic factors in invasive breast carcinoma.
El-Hafez AA; El Aaty Shawky A; Hasan B
Cancer Biomark; 2012; 12(4):149-54. PubMed ID: 23568005
[TBL] [Abstract][Full Text] [Related]
4. Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes.
Khande TA; Joshi AR; Khandeparkar SGS; Kulkarni MM; Gogate BP; Kakade AR; Sahu PD; Khillare CD
Indian J Cancer; 2020; 57(2):190-197. PubMed ID: 32445323
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters.
Ravikumar G; Ananthamurthy A
J Cancer Res Ther; 2014; 10(3):671-5. PubMed ID: 25313758
[TBL] [Abstract][Full Text] [Related]
6. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
7. Stromal expression of CD10 in breast carcinoma and its correlation with clinicopathological parameters.
Dhande AN; Sinai Khandeparkar SG; Joshi AR; Kulkarni MM; Pandya N; Mohanapure N; Aggarwal A; Patil G
South Asian J Cancer; 2019; 8(1):18-21. PubMed ID: 30766845
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
[TBL] [Abstract][Full Text] [Related]
9. The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma.
Yildirim HT; Nergiz D; Sadullahoglu C; Akgunduz Z; Yildirim S; Dogan S; Sezer C
Indian J Pathol Microbiol; 2020; 63(3):412-417. PubMed ID: 32769330
[TBL] [Abstract][Full Text] [Related]
10. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.
Hussein IA; Ahmed ST; Hameedi AD; Naji RZ; Alharbawi L; Alkhaytt M; Pity IS
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1025-1029. PubMed ID: 32334465
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Overexpression of Cyclin D1 in Tunisian Invasive Breast Carcinoma Women.
Bouzidi L; Makni S; Feki J; Kallel R; Graja S; Gouiaa N; Sellami-Boudawara T; Mellouli M
Arch Iran Med; 2022 Apr; 25(4):250-256. PubMed ID: 35942997
[TBL] [Abstract][Full Text] [Related]
13. Utility of TRPS-1 immunohistochemistry in diagnosis of metastatic breast carcinoma in cytology specimens.
Abdelwahed M; Yurtsever N; Savant D; Karam P; Gimenez C; Das K; Sheikh-Fayyaz S; Khutti S
J Am Soc Cytopathol; 2022; 11(6):345-351. PubMed ID: 36055933
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of lymphovascular invasion in carcinoma breast with CD34 and D2-40 and its correlation with other prognostic markers.
Agarwal S; Singh A; Bagga PK
Indian J Pathol Microbiol; 2018; 61(1):39-44. PubMed ID: 29567882
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Cyclin D1 and Human Epidermal Growth Factor Receptor 2 Neu Protein Expression in Head and Neck Squamous Cell Carcinoma.
Sinha S; Das S; Mohiyuddin SMA
Cureus; 2023 Feb; 15(2):e35526. PubMed ID: 37007344
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.
Aaltonen K; Amini RM; Landberg G; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H; Blomqvist C
Breast Cancer Res Treat; 2009 Jan; 113(1):75-82. PubMed ID: 18240019
[TBL] [Abstract][Full Text] [Related]
18. Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.
Villegas SL; Darb-Esfahani S; von Minckwitz G; Huober J; Weber K; Marmé F; Furlanetto J; Schem C; Pfitzner BM; Lederer B; Engels K; Kümmel S; Müller V; Mehta K; Denkert C; Loibl S
Breast Cancer Res Treat; 2018 Feb; 168(1):179-187. PubMed ID: 29177689
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.
Mylona E; Tzelepis K; Theohari I; Giannopoulou I; Papadimitriou C; Nakopoulou L
Histopathology; 2013 Feb; 62(3):472-80. PubMed ID: 23163571
[TBL] [Abstract][Full Text] [Related]
20. [Expression of ER, PR and cyclin D1 in breast infiltrating ductal carcinoma and their clinicopathological significance].
Wang ZB; Zhao P; Liu M; Li XH
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):514-7. PubMed ID: 15949328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
